The commentary of Donaldson and colleagues lists
several of the unanswered questions concerning the potential
oncogenicity of feline leukaemia virus (FeLV) and feline
immunodeficiency virus (FIV) in human beings. As a
contribution to this debate, we report a study in patients
with haematological neoplasms, carried out with
immunological and molecular techniques